Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07605546 · ClinicalTrials.gov registry record · NA
RAD ONC FREEDOM Oncology Pain
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT07605546 is a NA study that is actively recruiting participants, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 19 participants.
The verdict
NCT07605546, a NA study, is actively recruiting participants, sponsored by Jonsson Comprehensive Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This involves treating the pituitary hypophysis and thalamus to a dose of 90 Gy. These patients will have previously failed to achieve adequate pain control with opioid pain regimens and interventional approaches. The trial will involve a multidisciplinary approach involving radiation oncology, neurosurgery, palliative care, and medical oncology colleagues across UCLA.
Interventions
- RADIATION Radiosurgery
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2026-06-09 |
| Est. Completion | 2029-06-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07605546
The ClinicalTrials.gov registry entry for NCT07605546 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radiosurgery is the first listed.
NCT07605546 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07605546 about?
NCT07605546 is a clinical study titled "RAD ONC FREEDOM Oncology Pain". The investigators propose to conduct a study in medically refractory cancer pain patients utilizing radiosurgery to ablate the pituitary hypophysis, as well as neuromodulate the centromedian and parafascicular complexes within the thalami - the so-called triple target. This involves treating the pit...
What is the current status of trial NCT07605546?
This trial is currently recruiting. It is a NA study. The enrollment target is 19 participants. The study started on 2026-06-09. Estimated completion is 2029-06-01.
What interventions are being tested in trial NCT07605546?
The interventions under investigation include: Radiosurgery (RADIATION).
Who is sponsoring clinical trial NCT07605546?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.